Form D · Biotechnology
1910 Genetics Inc.
Cambridge, MA · CIK 0001855990
Offering snapshot reported Apr 19, 2021 · SEC filing
- Reported sold
- $25.7M Offering amount: $25.7M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 29, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Apr 19, 2021 | Initial | $25,709,907 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-396328
Source: Form D, filed Apr 19, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jory Bell | Director |
| Marc Foster | Director |
| Samir Kumar | Director |
| Jennifer O. Nwankwo | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
Labcentral 700 Main St.
Cambridge, MA, 02139
Cambridge, MA, 02139